Keywords: Amgen, Third-quarter 2011 financial results

Amgen 3rd-qtr 2011 profits nose dive on legal charges

Article | 25 October 2011

USA-based Amgen (Nasdaq: AMGN), the world’s largest biotechnology company, saw its third-quarter 2011 profit plunge to $454 million, compared to $1.2 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Amgen

Go to company listing